Raptiva Meningitis Attorneys

Raptiva Meningitis Side Effect

The Raptiva viral meningitis side effect has been associated with the pharmaceutical's active ingredient, Efalizumab. Meningitis is a neurological condition that can lead to brain damage, loss of functioning, and even death in some cases. The precise mechanism by which Efalizumab provokes or catalyzes viral meningitis in some cases is not well understood, although the manufacturer, Genentech Inc., as well as the FDA acknowledge that increased risk for meningitis is indeed a Raptiva side effect.

Raptiva was designed to help patients recover faster from a skin condition called psoriasis. This is a relatively common skin abnormality that affects over 2 million people in the U.S. and many more million worldwide. There's no cure for psoriasis, but drugs like Raptiva have clinically been shown to help ameliorate some of the symptoms.

Efalizumab works by changing the rate at which T-cells grow in affected areas. Essentially, since psoriasis is caused by runaway cell growth, by inhibiting this growth, Raptiva relieves the condition. The problem, it appears, is that the recalled pharmaceutical Raptiva also interferes with a complex biochemical mechanism that activates the virus that causes viral meningitis.

In addition to seeking treatment for your illness and talking to your physician about how to wean yourself off of Efalizumab safely, you may want to investigate whether to take legal action to seek remuneration for your pain and suffering. The Raptiva meningitis side effect attorneys at Anapol Schwartz are here to help. We can provide a free, no obligation consultation about your Raptiva meningitis case. We boast vast trial experience and a deep knowledge of the Raptiva recall.

CALL TODAY 866.735.2792